First-Line Pembrolizumab Plus Chemotherapy for HER2-Negative Advanced Gastric Cancer: China Subgroup Analysis of the Randomized Phase 3 KEYNOTE-859 StudyShukui Qin, Shouguo Li, Suxia Luo et al.|Advances in Therapy|2025Cited by 9
The enigmatic interplay of immune cells and abnormal spermatozoa through Mendelian randomizationFu‐Chun Zheng, Bin Fu, Sheng Li et al.|American Journal of Reproductive Immunology|2024Cited by 2